Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Cognitive Activation Behavioral Therapy for MCI: A Randomized Waitlist-Control and Delayed Active-Control Study

NCT01641328 is registered in ClinicalTrials.gov with Rotman Research Institute at Baycrest as lead sponsor.

NCT NCT01641328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01641328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Cognitive Activation Behavioral Therapy for MCI: A Randomized Waitlist-Control and Delayed Active-Control Study
Lead sponsor
Rotman Research Institute at Baycrest
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2012
Completion date
July 31, 2013
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment